Cardiac troponin – Medxy AI

Macrotroponin Complexes and Risk of Cardiovascular Events: Implications for Cardiac Troponin Testing in Population Risk Stratification

By MedXY 09/11/2026

Macrotroponin complexes commonly cause discordant cardiac troponin elevations in the general population, notably troponin I, without conferring increased cardiovascular risk, underscoring the need to recognize assay interference for accurate risk prediction.

Cardiology news Pathology & Lab Medicine/Bệnh học

Why the cTnI/cTnT Ratio May Matter: A New Signal for Distinguishing Acute Necrotic From Chronic Myocardial Injury

By MedXY 05/12/2026

A large multicohort and experimental study suggests the cTnI/cTnT ratio is biologically informative, separates acute from chronic myocardial injury, and modestly improves type 1 versus type 2 MI discrimination.

Cardiology news

Troponin Assay Transitions: Increased Clinical Burden Without Improved Cardiovascular Outcomes

By MedXY 12/24/2025

Switching from high-sensitivity troponin I to T significantly increases diagnoses of myocardial injury and hospital admissions without improving long-term cardiovascular outcomes, while low-threshold troponin I remains a safe tool for rapid rule-out.

Cardiology Clinical Updates Neurology news

High-Sensitivity Cardiac Troponins and Dementia Risk: Insights from Longitudinal Cohort Studies

By MedXY 11/28/2025

Elevated high-sensitivity cardiac troponin I and T levels, indicative of subclinical myocardial injury in midlife, are associated with accelerated cognitive decline, structural brain changes, and increased dementia risk in later life.